Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
1.596
-0.014 (-0.85%)
Aug 10, 2026, 9:54 AM EDT - Market open
Imunon Employees
Imunon had 20 employees as of December 31, 2025. The number of employees decreased by 5 or -20.00% compared to the previous year.
Employees
20
Change (1Y)
-5
Growth (1Y)
-20.00%
Revenue / Employee
n/a
Profits / Employee
-$732,078
Market Cap
6.71M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 20 | -5 | -20.00% |
| Dec 31, 2024 | 25 | -8 | -24.24% |
| Dec 31, 2023 | 33 | 2 | 6.45% |
| Dec 31, 2022 | 31 | 2 | 6.90% |
| Dec 31, 2021 | 29 | 2 | 7.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| FibroBiologics | 15 |
| Processa Pharmaceuticals | 12 |
| Ensysce Biosciences | 10 |
| AEON Biopharma | 8 |
| Alzamend Neuro | 6 |
| XTL Biopharmaceuticals | 5 |
| Acurx Pharmaceuticals | 4 |
IMNN News
- 11 days ago - Imunon provides update on OVATION 3 trial of IMNN-001 - TheFly
- 11 days ago - IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer - GlobeNewsWire
- 18 days ago - IMUNON to Present IMNN-001 Data at Inaugural AACR Conference on Drug Discovery and Development - GlobeNewsWire
- 20 days ago - Imunon announces new preliminary data from IMNN-001 trial - TheFly
- 20 days ago - IMUNON Reports Positive Phase 2 MRD Clinical Data for IMNN-001, Demonstrating the Successful Overcoming of Historical IL-12 Safety Barriers in Frontline Ovarian Cancer - GlobeNewsWire
- 5 weeks ago - Imunon interim CFO Jeffrey Church to retire, Josh Blacher to succeed - TheFly
- 6 weeks ago - Imunon Transcript: Life Sciences Virtual Investor Forum - Transcripts
- 6 weeks ago - Imunon Slides: Life Sciences Virtual Investor Forum - Filings